Videla, L., Benejam, B., Pegueroles, J., Carmona-Iragui, M., Padilla, C., Fernández, S., ... & Fortea, J. (2022). Longitudinal clinical and cognitive changes along the Alzheimer disease continuum in Down syndrome. JAMA network open, 5(8), e2225573-e2225573./Fortea, J., Zaman, S. H., Hartley, S., Rafii, M. S., Head, E., & Carmona-Iragui, M. (2021). Alzheimer's disease associated with Down syndrome: a genetic form of dementia. The Lancet Neurology, 20(11), 930-942./ Benejam, B., Aranha, M. R., Videla, L., Padilla, C., Valldeneu, S., Fernández, S., ... & Fortea, J. (2022). Neural correlates of episodic memory in adults with Down syndrome and Alzheimer’s disease. Alzheimer's research & therapy, 14(1), 123./Jin, M., Xu, R., Wang, L., Alam, M. M., Ma, Z., Zhu, S., ... & Jiang, P. (2022). Type-I-interferon signaling drives microglial dysfunction and senescence in human iPSC models of Down syndrome and Alzheimer’s disease. Cell Stem Cell, 29(7), 1135-1153./Petersen, M. E., Rafii, M. S., Zhang, F., Hall, J., Julovich, D., Ances, B. M., ... & Alzheimer’s Biomarker Consortium–Down Syndrome (ABC-DS). (2021). Plasma total-tau and neurofilament light chain as diagnostic biomarkers of Alzheimer’s disease dementia and mild cognitive impairment in adults with Down syndrome. Journal of Alzheimer’s Disease, 79(2), 671-681./